These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 15134823)

  • 1. Aldosterone-induced vasculopathy.
    Struthers AD
    Mol Cell Endocrinol; 2004 Mar; 217(1-2):239-41. PubMed ID: 15134823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardioprotection by aldosterone receptor antagonism in heart failure. Part I. The role of aldosterone in heart failure.
    Dieterich HA; Wendt C; Saborowski F
    Fiziol Cheloveka; 2005; 31(6):97-105. PubMed ID: 16366159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aldosterone-synthase overexpression in heart: a tool to explore aldosterone's effects.
    Heymes C; Garnier A; Fuchs S; Bendall JK; Nehme J; Ambroisine ML; Robidel E; Swynghedauw B; Milliez P; Delcayre C
    Mol Cell Endocrinol; 2004 Mar; 217(1-2):213-9. PubMed ID: 15134820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fiftieth anniversary of aldosterone: from discovery to cardiovascular therapy.
    Tan LB; Schlosshan D; Barker D
    Int J Cardiol; 2004 Sep; 96(3):321-33. PubMed ID: 15310530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aldosterone inhibition reduces the risk of sudden cardiac death in patients with heart failure.
    Anand K; Mooss AN; Mohiuddin SM
    J Renin Angiotensin Aldosterone Syst; 2006 Mar; 7(1):15-9. PubMed ID: 17083069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurohormones and heart failure: the importance of aldosterone.
    Odedra K; Ferro A
    Int J Clin Pract; 2006 Jul; 60(7):835-46. PubMed ID: 16846401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathophysiology of heart failure following myocardial infarction.
    Struthers AD
    Heart; 2005 May; 91 Suppl 2(Suppl 2):ii14-6; discussion ii31, ii43-8. PubMed ID: 15831601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spironolactone has antiarrhythmic activity in ischaemic cardiac patients without cardiac failure.
    Shah NC; Pringle SD; Donnan PT; Struthers AD
    J Hypertens; 2007 Nov; 25(11):2345-51. PubMed ID: 17921831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of aldosterone blockade in heart failure.
    Pitt B
    Heart Fail Clin; 2005 Apr; 1(1):49-56. PubMed ID: 17386833
    [No Abstract]   [Full Text] [Related]  

  • 10. Uncertainty on the use of aldosterone antagonists for primary therapy for sudden cardiac death in the setting of implanted devices.
    Kloner RA; Cannom DS
    Circulation; 2007 Jun; 115(23):2983-9; discussion 2989. PubMed ID: 17562969
    [No Abstract]   [Full Text] [Related]  

  • 11. Aldosterone receptor antagonism in heart failure.
    Jennings DL; Kalus JS; O'Dell KM
    Pharmacotherapy; 2005 Aug; 25(8):1126-33. PubMed ID: 16207104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aldosterone blockade in heart failure.
    Struthers AD
    J Renin Angiotensin Aldosterone Syst; 2004 Sep; 5 Suppl 1():S23-7. PubMed ID: 15526239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aldosterone and cardiovascular disease.
    Gaddam KK; Pimenta E; Husain S; Calhoun DA
    Curr Probl Cardiol; 2009 Feb; 34(2):51-84. PubMed ID: 19135616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sodium retention in heart failure and cirrhosis: potential role of natriuretic doses of mineralocorticoid antagonist?
    Bansal S; Lindenfeld J; Schrier RW
    Circ Heart Fail; 2009 Jul; 2(4):370-6. PubMed ID: 19808361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aldosterone receptor antagonism and heart failure: insights from an outpatient clinic.
    Mariotti R; Borelli G; Coceani M; Zingaro S; Barison A; Morelli I; Rondinini L
    J Clin Pharm Ther; 2008 Aug; 33(4):349-56. PubMed ID: 18613852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of aldosterone on vascular pathophysiology.
    Struthers AD
    Congest Heart Fail; 2002; 8(1):18-22. PubMed ID: 11821624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sudden cardiac death after heart failure; symptomatic versus disease treatment? An editorial comment.
    Buckberg GD;
    Heart Fail Rev; 2004 Oct; 9(4):347-51. PubMed ID: 15886980
    [No Abstract]   [Full Text] [Related]  

  • 18. Aldosterone blockade over and above ACE-inhibitors in patients with coronary artery disease but without heart failure.
    Shah NC; Pringle S; Struthers A
    J Renin Angiotensin Aldosterone Syst; 2006 Mar; 7(1):20-30. PubMed ID: 17083070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurohormonal regulation of cardiac ion channels in chronic heart failure.
    Kurokawa J; Abriel H
    J Cardiovasc Pharmacol; 2009 Aug; 54(2):98-105. PubMed ID: 19597366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-selective nonsteroidal anti-inflammatory drugs and cardiovascular events: is aldosterone the silent partner in crime?
    Knights KM; Mangoni AA; Miners JO
    Br J Clin Pharmacol; 2006 Jun; 61(6):738-40. PubMed ID: 16722838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.